ADNOCDRILL earnings per share for the last quarter are 0.06 AED whereas the estimation was 0.07 AED which accounts for -6.41% surprise. Företagets omsättning för samma period uppgår till 3.26 B AED trots den uppskattade siffran 3.25 B AED. Estimated earnings per share for the next quarter are 0.07 AED, and revenue is expected to reach 3.41 B AED. Also watch annual changes over time to get a bigger picture of ADNOCDRILL earnings per share and revenue dynamics.